MENUNews Archive
Date: 04/17/2021
High expression levels of the gene TRIM63 can serve as an accurate and sensitive biomarker of a subtype of kidney cancer known as microphthalmia-associated transcription factor family aberration-associated renal cell carcinomas — or MiTF renal cell carcinoma.
Date: 04/12/2021
Although clinical guidelines encourage the use of palliative care during end of life care, they aren't being followed for many ovarian cancer patients, particularly for people of color. Palliative care is particularly relevant for people with ovarian cancer because they’re often diagnosed once their cancer has already progressed to an advanced stage. By that point, survival is unlikely; just 17% of those with stage IV ovarian cancer live for at least five years after diagnosis.
Date: 04/01/2021
The findings not only shed new light on cancer immunology, they also suggest clinical trials related to this key target — an interaction that destabilizes the important p53 tumor suppressor protein — may unnecessarily be excluding a large number of patients.
Date: 03/25/2021
A team of researchers from the University of Michigan and the Henry Ford Health System is shedding new light on important differences in triple-negative breast cancer tumors from African, African American and white patients.
Date: 03/24/2021
Immunotherapy researchers have discovered how a subset of T cells known as memory T cells are generated in melanoma survivors with vitiligo and able to function for years after a tumor is gone.
Date: 03/22/2021
Prebiotics are an intriguing potential approach to curbing some of the severe side effects that life-saving immunotherapy treatments can wreak on the gut, according to an analysis of recent studies and clinical trials.
Date: 03/20/2021
The awards recognize faculty members’ outstanding clinical research and promising future in oncology.
Date: 03/20/2021
This RNA molecule, cataloged in scientific databases simply as Linc00402, helps activate immune defenders known as T cells in response to the presence of foreign human cells, according to a new study.
Date: 03/12/2021
When standard cancer treatments don’t work, or if doctors can’t determine where a patient’s cancer originated, genomic sequencing can help pinpoint mutations in a tumor that might be matched with medicines targeting those specific alterations.
Date: 03/10/2021
The modeling study looks at the benefits and harms associated with various low-dose computed tomography screening strategies—identifying those that result in the most benefits for a given level of screening.